Skip to main content
. 2022 Aug 30;11:e79848. doi: 10.7554/eLife.79848

Figure 2. Target specificity and retrograde labeling efficacy of envA-pseudotyped RVdG-CVS-N2c particles, produced in BHK-eT cells.

(A) Illustration of the injection scheme (left) and corresponding representative confocal images demonstrating the targeting specificity of CVS-N2c particles (green) to FLAG3X tagged cells (magenta) along with retrograde labeling to EC layer 2 cells (rightmost image, EC layers are separated by dashed lines and their numbers are denoted above). (B) Illustration of the injection scheme (top left) and corresponding representative confocal images demonstrating efficiency and specificity of CVS-N2c-mediated retrograde labeling from adult-born DGCs. (C) Illustration of the injection scheme (top left) and corresponding representative confocal images demonstrating target specificity, with no accompanying retrograde labeling, in the absence of the rabies glycoprotein in any of its projections in four separate experiments.

Figure 2.

Figure 2—figure supplement 1. Transsynaptic retrograde labeling pattern from adult-born hippocampal DGCs in subcortical regions.

Figure 2—figure supplement 1.

(A and B) Transsynaptic retrograde labeling with CV-N2c vectors from adult-born cells in the hippocampal DG, using the Ascl1creERT2 line (A) reveals identical labeling pattern in subcortical regions as following the same manipulation on the general population of DGCs, using the DG-specific Prox1cre line (B) MS – Medial Septal Nucleus; SuM – Supramammilary Nucleus; MnR – Median nucleus Raphe.